-
公开(公告)号:US09040259B2
公开(公告)日:2015-05-26
申请号:US13046304
申请日:2011-03-11
IPC分类号: C12P19/62 , C12P17/18 , C07D471/18 , C07D487/18 , C07D493/18 , C07K14/36 , C12N15/52 , C12N15/70 , C12N15/76 , C12N1/20
CPC分类号: C07D498/18 , C07D405/12 , C07D471/18 , C07D487/18 , C07D493/18 , C07K14/36 , C12N15/52 , C12N15/70 , C12N15/76 , C12P17/188
摘要: The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. One important area is the isolation and potential use of novel FKBP-ligand analogs and host cells that produce these compounds. The invention is particularly concerned with methods for the efficient transformation of strains that produce FKBP analogs and recombinant cells in which cloned genes or gene cassettes are expressed to generate novel compounds such as polyketide (especially rapamycin) FKBP-ligand analogs, and to processes for their preparation, and to means employed therein (e.g. nucleic acids, vectors, gene cassettes and genetically modified strains).
摘要翻译: 本发明涉及聚酮化合物和其它天然产物的生产以及化合物和单个新化合物的文库。 一个重要的领域是产生这些化合物的新型FKBP-配体类似物和宿主细胞的分离和潜在用途。 本发明特别涉及用于产生FKBP类似物和重组细胞的菌株的有效转化的方法,其中克隆的基因或基因盒被表达以产生新的化合物,例如聚酮化合物(特别是雷帕霉素)FKBP-配体类似物, 制备和其中使用的手段(例如核酸,载体,基因盒和遗传修饰的菌株)。
-
公开(公告)号:US20110165633A1
公开(公告)日:2011-07-07
申请号:US13046304
申请日:2011-03-11
IPC分类号: C12P17/18
CPC分类号: C07D498/18 , C07D405/12 , C07D471/18 , C07D487/18 , C07D493/18 , C07K14/36 , C12N15/52 , C12N15/70 , C12N15/76 , C12P17/188
摘要: The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. One important area is the isolation and potential use of novel FKBP-ligand analogues and host cells that produce these compounds. The invention is particularly concerned with methods for the efficient transformation of strains that produce FKBP analogues and recombinant cells in which cloned genes or gene cassettes are expressed to generate novel compounds such as polyketide (especially rapamycin) FKBP-ligand analogues, and to processes for their preparation, and to means employed therein (e.g. nucleic acids, vectors, gene cassettes and genetically modified strains).
摘要翻译: 本发明涉及聚酮化合物和其它天然产物的生产以及化合物和单个新化合物的文库。 一个重要的领域是产生这些化合物的新型FKBP-配体类似物和宿主细胞的分离和潜在的使用。 本发明特别涉及有效转化产生FKBP类似物的菌株和重组细胞的方法,其中克隆的基因或基因盒被表达以产生新的化合物,例如聚酮化合物(特别是雷帕霉素)FKBP-配体类似物, 制备和其中使用的手段(例如核酸,载体,基因盒和遗传修饰的菌株)。
-
公开(公告)号:US07390895B2
公开(公告)日:2008-06-24
申请号:US11778264
申请日:2007-07-16
IPC分类号: C07D498/18
CPC分类号: C07D498/18 , C07D405/12 , C07D471/18 , C07D487/18 , C07D493/18 , C07K14/36 , C12N15/52 , C12N15/70 , C12N15/76 , C12P17/188
摘要: The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. One important area is the isolation and potential use of novel FKBP-ligand analogues and host cells that produce these compounds. The invention is particularly concerned with methods for the efficient transformation of strains that produce FKBP analogues and recombinant cells in which cloned genes or gene cassettes are expressed to generate novel compounds such as polyketide (especially rapamycin) FKBP-ligand analogues, and to processes for their preparation, and to means employed therein (e.g. nucleic acids, vectors, gene cassettes and genetically modified strains).
摘要翻译: 本发明涉及聚酮化合物和其它天然产物的生产以及化合物和单个新化合物的文库。 一个重要的领域是产生这些化合物的新型FKBP-配体类似物和宿主细胞的分离和潜在的使用。 本发明特别涉及有效转化产生FKBP类似物的菌株和重组细胞的方法,其中克隆的基因或基因盒被表达以产生新的化合物,例如聚酮化合物(特别是雷帕霉素)FKBP-配体类似物, 制备和其中使用的手段(例如核酸,载体,基因盒和遗传修饰的菌株)。
-
公开(公告)号:US20080039486A1
公开(公告)日:2008-02-14
申请号:US11778319
申请日:2007-07-16
申请人: Matthew Gregory , Sabine Gaisser , Hryoje Petkovic , Steven Moss
发明人: Matthew Gregory , Sabine Gaisser , Hryoje Petkovic , Steven Moss
IPC分类号: A61K31/4353 , A61K31/407 , A61P35/00
CPC分类号: C07D498/18 , C07D405/12 , C07D471/18 , C07D487/18 , C07D493/18 , C07K14/36 , C12N15/52 , C12N15/70 , C12N15/76 , C12P17/188
摘要: The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. One important area is the isolation and potential use of novel FKBP-ligand analogues and host cells that produce these compounds. The invention is particularly concerned with methods for the efficient transformation of strains that produce FKBP analogues and recombinant cells in which cloned genes or gene cassettes are expressed to generate novel compounds such as polyketide (especially rapamycin) FKBP-ligand analogues, and to processes for their preparation, and to means employed therein (e.g. nucleic acids, vectors, gene cassettes and genetically modified strains).
-
15.
公开(公告)号:US20060247828A1
公开(公告)日:2006-11-02
申请号:US11221716
申请日:2005-09-09
申请人: Ricardo Ardila , Dean Farnham , Nick Feng , Robert Ferguson , Patrick Krohn , Steven Moss
发明人: Ricardo Ardila , Dean Farnham , Nick Feng , Robert Ferguson , Patrick Krohn , Steven Moss
IPC分类号: G01C23/00
摘要: A method of accounting for errors in the altitude reporting of a terrain alert and warning system (TAWS) is disclosed wherein errors due to non-standard atmospheric conditions, incorrect altimeter setting and air data computer (ADC) sensor error are detected and corrected for by compensating ADC altitudes for cold temperatures as well as using global positioning system (GPS) altitude data to confirm the accuracy of the ADC altitude information at all times.
-
公开(公告)号:US20060162058A1
公开(公告)日:2006-07-27
申请号:US11040938
申请日:2005-01-21
申请人: Steven Moss , Mart Betts , Keith Lindsey
发明人: Steven Moss , Mart Betts , Keith Lindsey
IPC分类号: E03D9/08
CPC分类号: E03D9/08
摘要: A combination toilet seat and bidet apparatus includes a toilet seat member formed with a top wall, a continuous arcuate outer sidewall extending between opposite ends of a back wall and an inner sidewall defining, in part, a seat opening. An arcuate nozzle support arm is mounted on the seat member for rotation about an axis generally normal to the longitudinal axis of the seat member. An operating handle is connected to the arm at one side of the seat and a water flow control valve and operating handle are mounted on the seat opposite the arm operating handle for controlling water flow to a water jet nozzle mounted on the arm. The arm is adapted to be moved to selected working positions by the arm operating handle, and water flow may be selectively varied at will.
摘要翻译: 组合马桶座圈和坐浴盆装置包括形成有顶壁的马桶座圈构件,在后壁的相对端部之间延伸的连续弧形外侧壁和部分地限定座椅开口的内侧壁。 弧形喷嘴支撑臂安装在座椅构件上,用于围绕基本上垂直于座椅构件的纵向轴线的轴线旋转。 操作手柄在座椅的一侧连接到臂上,并且水流控制阀和操作手柄安装在与臂操作手柄相对的座上,用于控制到安装在臂上的水喷嘴的水流。 手臂适于通过手臂操作手柄移动到所选择的工作位置,并且水流可以随意选择性地变化。
-
公开(公告)号:US20050272132A1
公开(公告)日:2005-12-08
申请号:US10497135
申请日:2003-07-16
申请人: Matthew Gregory , Sabine Gaisser , Hrvoje Petkovic , Steven Moss
发明人: Matthew Gregory , Sabine Gaisser , Hrvoje Petkovic , Steven Moss
IPC分类号: C12N15/09 , A61K31/407 , A61K31/436 , A61K31/706 , A61P31/10 , A61P35/00 , A61P37/04 , C07D493/18 , C07D498/18 , C07H15/04 , C07K14/36 , C12N1/21 , C12N15/10 , C12N15/52 , C12N15/70 , C12N15/76 , C12P17/18 , C12P19/62 , C12R1/55 , C12P19/28 , C12N15/74
CPC分类号: C07D498/18 , C07D405/12 , C07D471/18 , C07D487/18 , C07D493/18 , C07K14/36 , C12N15/52 , C12N15/70 , C12N15/76 , C12P17/188
摘要: The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. One important area is the isolation and potential use of novel FKBP-ligand analogues and host cells that produce these compounds. The invention is particularly concerned with methods for the efficient transformation of strains that produce FKBP analogues and recombinant cells in which cloned genes or gene cassettes are expressed to generate novel compounds such as polyketide (especially rapamycin) FKBP-ligand analogues, and to processes for their,preparation, and to means employed therein (e.g. nucleic acids, vectors, gene cassettes and genetically modified strains).
摘要翻译: 本发明涉及聚酮化合物和其它天然产物的生产以及化合物和单个新化合物的文库。 一个重要的领域是产生这些化合物的新型FKBP-配体类似物和宿主细胞的分离和潜在的使用。 本发明特别涉及有效转化产生FKBP类似物的菌株和重组细胞的方法,其中克隆的基因或基因盒被表达以产生新的化合物,例如聚酮化合物(特别是雷帕霉素)FKBP-配体类似物, ,制备和其中使用的手段(例如核酸,载体,基因盒和遗传修饰的菌株)。
-
公开(公告)号:US20180258100A1
公开(公告)日:2018-09-13
申请号:US15756034
申请日:2016-08-26
IPC分类号: C07D498/18 , A61P25/28 , A61P25/08 , A61P35/02 , A61P37/02
CPC分类号: C07D498/18 , A61K31/436 , A61K31/573 , A61K38/13 , A61K45/06 , A61K2300/00 , A61P25/08 , A61P25/28 , A61P35/02 , A61P37/02
摘要: In various embodiments novel rapamycin analogs are provides that show improved mTORC1 specificity.
-
公开(公告)号:US20110027185A1
公开(公告)日:2011-02-03
申请号:US12667625
申请日:2008-07-14
IPC分类号: A61K39/395 , G01N33/566 , C07K16/18 , A61K49/00 , A61K31/365 , C07D313/00 , A61P35/00 , A61P29/00 , A61P17/06 , A61P27/02 , A61P9/10
CPC分类号: G01N33/574 , G01N33/6893 , G01N2500/00 , G01N2800/164
摘要: The present invention relates to methods of screening for agents that bind to FBP21. In particular the present invention provides a method of identifying anti-angiogenic agents by screening for agents which are able to bind to FBP21. Compounds identified using the methods and screens of the present invention are useful in the prevention and treatment of conditions associated with angiogenesis.
摘要翻译: 本发明涉及筛选结合FBP21的试剂的方法。 特别地,本发明提供了通过筛选能够结合FBP21的试剂来鉴定抗血管生成剂的方法。 使用本发明的方法和筛选鉴定的化合物可用于预防和治疗与血管发生相关的病症。
-
20.
公开(公告)号:US20100210597A1
公开(公告)日:2010-08-19
申请号:US12526605
申请日:2008-03-03
申请人: Steven Moss , Christine Martin , Ming Zhang
发明人: Steven Moss , Christine Martin , Ming Zhang
IPC分类号: A61K31/675 , C07D225/06 , A61K31/33 , A61P35/00 , A61P31/00 , A61P25/00 , A61P37/06 , A61P9/00
CPC分类号: C07D225/06
摘要: According to the invention there are provided derivatives of a C21-deoxy ansamycin or salt thereof which contain a 1-hydroxyphenyl moiety bearing at position 3 an aminocarboxy substituent, in which position 5 and the aminocarboxy substituent at position 3 are connected by an aliphatic chain of varying length characterised in that the 1-hydroxy position of the phenyl ring is derivatised by an aminoalkyleneaminocarbonyl group, which alkylene group (which may optionally be substituted by alkyl groups) has a chain length of 2 or 3 carbon atoms, a phosphoric acid, or a phosphoric acid ester (such as an alkyl ester) group, or a salt thereof, and which derivatising group increases the water solubility and/or the bioavailability of the parent molecule. Such compounds are useful in therapy eg in the treatment of cancer and B-cell malignancies.
摘要翻译: 根据本发明,提供了一种C21-脱氧安莎霉素或其盐的衍生物,其含有在位置3具有氨基羧基取代基的1-羟基苯基部分,其中位置5和位置3上的氨基羧基取代基通过脂族链连接 变化的长度,其特征在于苯环的1-羟基位置被氨基亚烷基氨基羰基衍生,该亚烷基(其可以任选被烷基取代)具有2或3个碳原子的链长,磷酸或 磷酸酯(例如烷基酯)或其盐,并且该衍生基增加了母体分子的水溶性和/或生物利用度。 这样的化合物可用于治疗,例如治疗癌症和B细胞恶性肿瘤。
-
-
-
-
-
-
-
-
-